Literature DB >> 10408691

Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.

X H Pei1, Y Nakanishi, K Takayama, F Bai, N Hara.   

Abstract

We and other researchers have previously found that colony-stimulating factors (CSFs), which generally include granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF), promote invasion by lung cancer cells. In the present study, we studied the effects of these CSFs on gelatinase production, urokinase plasminogen activator (uPA) production and their activity in human lung cancer cells. Gelatin zymographs of conditioned media derived from human lung adenocarcinoma cell lines revealed two major bands of gelatinase activity at 68 and 92 kDa, which were characterized as matrix metalloproteinase (MMP)-2 and MMP-9 respectively. Treatment with CSFs increased the 68- and 92-kDa activity and converted some of a 92-kDa proenzyme to an 82-kDa enzyme that was consistent with an active form of the MMP-9. Plasminogen activator zymographs of the conditioned media from the cancer cells showed that CSF treatment resulted in an increase in a 48-55 kDa plasminogen-dependent gelatinolytic activity that was characterized as human uPA. The conditioned medium from the cancer cells treated with CSFs stimulated the conversion of plasminogen to plasmin, providing a direct demonstration of the ability of enhanced uPA to increase plasmin-dependent proteolysis. The enhanced invasive behaviour of the cancer cells stimulated by CSFs was well correlated with the increase in MMPs and uPA activities. These data suggest that the enhanced production of extracellular matrix-degrading proteinases by the cancer cells in response to CSF treatment may represent a biochemical mechanism which promotes the invasive behaviour of the cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408691      PMCID: PMC2362164          DOI: 10.1038/sj.bjc.6690009

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 2.  Regulatory pathways in tumor growth and invasion.

Authors:  M Herlyn; S B Malkowicz
Journal:  Lab Invest       Date:  1991-09       Impact factor: 5.662

3.  Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.

Authors:  A Teti; A De Giorgi; M T Spinella; S Migliaccio; R Canipari; A Onetti Muda; T Faraggiana
Journal:  Int J Cancer       Date:  1997-09-17       Impact factor: 7.396

Review 4.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Authors:  J E Testa; J P Quigley
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

5.  Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony-stimulating factors and other agents.

Authors:  J A Hamilton; G Vairo; K R Knight; B G Cocks
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

6.  Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: increased urokinase-type plasminogen activator activity.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; K Royston; J A Hamilton
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

7.  Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.

Authors:  M J Niedbala; M S Picarella
Journal:  Blood       Date:  1992-02-01       Impact factor: 22.113

8.  Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein.

Authors:  P C Roche; J D Campeau; S T Shaw
Journal:  Biochim Biophys Acta       Date:  1983-05-30

Review 9.  Type IV collagenases in tumor invasion and metastasis.

Authors:  W G Stetler-Stevenson
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

10.  Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

Authors:  M V Cubellis; T C Wun; F Blasi
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

View more
  22 in total

Review 1.  The macrophage growth factor CSF-1 in mammary gland development and tumor progression.

Authors:  Elaine Y Lin; Valerie Gouon-Evans; Andrew V Nguyen; Jeffrey W Pollard
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

Authors:  Jasti S Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A Joseph; Sajani S Lakka
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

3.  Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma.

Authors:  Maria Kowalska; Joanna Tajer; Magdalena Chechlinska; Malgorzata Fuksiewicz; Beata Kotowicz; Janina Kaminska; Jan Walewski
Journal:  Med Oncol       Date:  2011-06-30       Impact factor: 3.064

4.  Pleomorphic carcinoma of the lung producing granulocyte colony-stimulating factor: report of a case.

Authors:  Hironobu Wada; Shigetoshi Yoshida; Fumihiro Ishibashi; Teruaki Mizobuchi; Yasumitsu Moriya; Hidehisa Hoshino; Tatsuro Okamoto; Makoto Suzuki; Kiyoshi Shibuya; Ichiro Yoshino
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

5.  Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.

Authors:  Barbara Mroczko; Maciej Szmitkowski; Urszula Wereszczyńska-Siemiatkowska; Bogna Okulczyk
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

6.  A case of anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor.

Authors:  Toru Murata; Masaki Terasaki; Kenji Sakaguchi; Masayuki Okubo; Yasuyuki Fukami; Kazumi Nishimae; Yasuhiko Kitayama; Shoji Hoshi
Journal:  Clin J Gastroenterol       Date:  2009-01-15

7.  Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.

Authors:  Yuanyuan Ma; Dongming Liang; Jian Liu; Karol Axcrona; Gunnar Kvalheim; Karl-Erik Giercksky; Jahn M Nesland; Zhenhe Suo
Journal:  Tumour Biol       Date:  2012-01-18

8.  Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells.

Authors:  Yao-Huei Huang; Pei-Ming Yang; Qiu-Yu Chuah; Yi-Jang Lee; Yi-Fen Hsieh; Chih-Wen Peng; Shu-Jun Chiu
Journal:  Autophagy       Date:  2014-04-30       Impact factor: 16.016

9.  Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis.

Authors:  Hisamitsu Ide; Kiyohiko Hatake; Yuichi Terado; Hiroyuki Tsukino; Takatsugu Okegawa; Kikuo Nutahara; Eiji Higashihara; Shigeo Horie
Journal:  Hum Cell       Date:  2008-02       Impact factor: 4.174

10.  Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.

Authors:  Barbara Mroczko; Maciej Szmitkowski; Urszula Wereszczyńska-Siemiatkowska; Bogna Okulczyk; Bogusław Kedra
Journal:  Int J Colorectal Dis       Date:  2006-03-07       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.